Developing enabling technologies for the success of cancer immunotherapy.
Sznol
Mario
M
D019496:Cancer Vaccines / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods* / Q000639:trends*; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*
D019496:Cancer Vaccines